Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any microlissencephaly in which the cause of the disease is a mutation in the KATNB1 gene.
Features include always present findings: Seizure, Motor delay, Enlarged brain ventricles (ventriculomegaly), and Overactive reflexes (hyperreflexia) and others; and common findings: Shrinkage of the cerebellum (cerebellar atrophy), Enlarged cisterna magna, Pachygyria, and Macrotia and others. 30 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Seizure, Enlarged brain ventricles (ventriculomegaly), Overactive reflexes (hyperreflexia) |
KATNB1 encodes katanin regulatory subunit B1 (655 aa). Participates in a complex which severs microtubules in an ATP-dependent manner. May act to target the enzymatic subunit of this complex to sites of action such as the centrosome. Highest expression in Testis (84.6 TPM) and Brain Cortex (54.6 TPM).
Lissencephaly 6 with microcephaly is associated with mutations in the KATNB1 gene on chromosome 16.
KATNB1 is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for KATNB1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 8 always present features, 6 common features.
No clinical trials have been registered for lissencephaly 6 with microcephaly.
8 publications have been identified in PubMed for lissencephaly 6 with microcephaly. Research spans Case Report / Case Series (38%), Review / Meta-Analysis (25%), and Basic Science / Preclinical (25%).
Hwang S (2026). [PMID: 41152456](https://pubmed.ncbi.nlm.nih.gov/41152456/). *J Hum Genet*. [Epidemiology / Natural History]
Achkasova KA (2026). [PMID: 41892327](https://pubmed.ncbi.nlm.nih.gov/41892327/). *Cells*. [Review / Meta-Analysis]
Lelli S (2026). [PMID: 42033392](https://pubmed.ncbi.nlm.nih.gov/42033392/). *J Child Neurol*. [Case Report / Case Series]
Yu T (2025). [PMID: 40017707](https://pubmed.ncbi.nlm.nih.gov/40017707/). *Front Pediatr*. [Case Report / Case Series]
Ragona F (2025). [PMID: 41283299](https://pubmed.ncbi.nlm.nih.gov/41283299/). *NeuroSci*. [Review / Meta-Analysis]
Eun J (2025). [PMID: 39608368](https://pubmed.ncbi.nlm.nih.gov/39608368/). *Clin Exp Pediatr*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 2:00 AM UTC
Online Mendelian Inheritance in Man
Head and neck | 2 | Thin upper lip vermilion, Microcephaly |
Arms and legs | 2 | Tapered finger, Limb hypertonia |
Muscles | 1 | Shrinkage of the cerebellum (cerebellar atrophy) |
Srivastava P (2024). [PMID: 38912084](https://pubmed.ncbi.nlm.nih.gov/38912084/). *Cureus*. [Case Report / Case Series]
Kulis K (2024). [PMID: 38928581](https://pubmed.ncbi.nlm.nih.gov/38928581/). *Brain Sci*. [Basic Science / Preclinical]